Tag Archives: ECOM

Top 10 Safest Stocks To Watch For 2018

Hanesbrands (HBI) tumbled to the bottom of the S&P 500 today after missing earnings forecasts and offering disappointing guidance.

Agence France-Presse/Getty Images

Hanesbrandsdropped 16% to $18.98 today, while the S&P 500 rose 0.7% to 2,297.42.

Stifel’s Jim Duffy and team explain what went wrong:

Structural changes in US consumer and retail trends weighed on 4Q and HBI fell short in 4Q. These trends are expected to continue in FY17 and guidance was more cautious than prevailing estimates. Given the leverage and dependence on acquisitions for growth, we view visibility to underlying free cash generation key to valuation and we are discouraged by both 2016 results which were well short of plan and the outlook for FY17 operating cash flow which is a step backwards from prior FY16 guidance. With a reduction in 2017 CFO estimates from $795mn to $690mn we are lowering our 12-month target price from $26 to $23.

Top 10 Safest Stocks To Watch For 2018: Nordson Corporation(NDSN)

Advisors’ Opinion:

  • [By Monica Gerson]

    Nordson Corporation (NASDAQ: NDSN) is projected to post its quarterly earnings at $0.92 per share on revenue of $415.52 million. Nordson shares gained 0.88 percent to close at $75.74 on Friday.

  • [By Steve Symington]

    Nordson Corporation (NASDAQ:NDSN) released fiscal second-quarter 2017 results on Monday that easily exceeded expectations, highlighting broad-based organic growth and solid contributions from its recently acquired businesses.

  • [By Monica Gerson]

    Nordson Corporation (NASDAQ: NDSN) is estimated to post its quarterly earnings at $0.92 per share on revenue of $415.52 million.

    KLX Inc (NASDAQ: KLXI) is projected to report its quarterly earnings at $0.30 per share on revenue of $383.62 million.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on GlaxoSmithKline (GSK) , Chubb (CB) , XPO Logistics (XPO) , FedEx (FDX) and Nordson (NDSN) .

    Cramer was bearish on Prudential (PRU) , Advanced Semiconductor Engineering (ASX) and ZTO Express (ZTO) .

Top 10 Safest Stocks To Watch For 2018: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

  • [By Lisa Levin]

    In trading on Thursday, healthcare shares fell by 0.20 percent. Meanwhile, top losers in the sector included Horizon Pharma PLC (NASDAQ: HZNP), down 20 percent, and Insys Therapeutics Inc (NASDAQ: INSY), down 17 percent.

  • [By William Patalon III]

    Insys Therapeutics Inc. (NASDAQ: INSY) – our “War on Pain” biotech play – has given us a profit of more than 16% since we recommended the stock just two weeks ago.

  • [By Peter Graham]

    Small cap Insys Therapeutics (NASDAQ: INSY) is the seventh most shorted stock on the Nasdaq with short interest of 43.97% according to Highshortinterest.com. Insys Therapeutics is a small cap specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients quality of life. Using proprietary spray technology and capabilities to develop pharmaceutical cannabinoids,the Companyis developing a pipeline of products intending to address unmet medical needs and the clinical shortcomings of existing commercial products. INSYS currently markets SUBSYS庐 (fentanyl sublingual spray), CII, and SYNDROS庐 (dronabinol) oral solution, CII, a proprietary, orally administered liquid formulation of dronabinol.The Company aims to developmedications for potentially treating addiction to opioids, opioid overdose, epilepsy and other disease areas with a significant unmet need.

Top 10 Safest Stocks To Watch For 2018: Leucadia National Corporation(LUK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We delved into Kraft Heinz’s (KHC) earnings beat, and explained the impact of Leucadia National’s (LUK) investment in National Beef on its earnings.

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

  • [By Dan Caplinger]

    Leucadia National (NYSE:LUK) is a difficult business for many investors to understand. The combination of the Jefferies Group financial services company, the National Beef meat processing and supply company, and plenty of other smaller investments present a challenge for those seeking to know the ins and outs of what affects Leucadia’s results. In general, though, conditions in the financial industry have been more volatile than the rest of the business, and Jefferies, therefore, plays a bigger role in how the overall company does.

Top 10 Safest Stocks To Watch For 2018: United Natural Foods, Inc.(UNFI)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap natural andorganic foods stock United Natural Foods, Inc (NASDAQ: UNFI) reported fiscal Q4 2017 earnings after the Wednesday market close with shares closing up 5.29% after better-than-expected earnings results in a space thats facing deflation especially after the Amazon-Wholefoods deal was announced. Q4 net sales increased 5.7% to $2.34 billion as sales were positively impacted by the acquisitions of Haddon House Food Products, Inc. and Gourmet Guru, Inc (Due to the integration of these acquisitions, the financial impact of acquired businesses is no longer fully separable). Net income increased 12.1% to $38.9 million.

  • [By Peter Graham]

    A long term performance chart for the Hain Celestial Group shows shares having once strongly outperformed largely underperforming peers such as large capWhole Foods Market, Inc (NASDAQ: WFM) and small cap United Natural Foods, Inc (NASDAQ: UNFI):

  • [By Peter Graham]

    A long term performance chart for the Hain Celestial Group shows shares having once outperformed underperforming peers such as large capWhole Foods Market, Inc (NASDAQ: WFM) and small cap United Natural Foods, Inc (NASDAQ: UNFI):

  • [By Peter Graham]

    The Q1 2017 earnings report for small cap natural andorganic foods stock United Natural Foods, Inc (NASDAQ: UNFI) is scheduled for after the market closes onWednesday (December 7th). Shares tend to move in tandeem with Whole Foods Market, Inc (NASDAQ: WFM) who accounts for more than 30% of sales and were falling in September on concerns about WFM’s weakness with Wolfe Research’s Scott Mushkin commenting:

Top 10 Safest Stocks To Watch For 2018: ChannelAdvisor Corporation(ECOM )

Advisors’ Opinion:

  • [By Lisa Levin]

    ChannelAdvisor Corp (NASDAQ: ECOM) shares dropped 24 percent to $10.85 following Q4 results. ChannelAdvisor reported Q4 net income of $5.8 million on revenue of $31.8 million.

Top 10 Safest Stocks To Watch For 2018: Synutra International, Inc.(SYUT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Synutra International, Inc. (NASDAQ: SYUT) shares were also up, gaining 17 percent to $5.28 after the company disclosed that it has entered into a definitive merger agreement for "going private" transaction.

Top 10 Safest Stocks To Watch For 2018: Zynga Inc.(ZNGA)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap social media gaming stockZynga Inc (NASDAQ: ZNGA) reportedQ2 2017 earnings after the Wednesday market close. Revenue was above guidance by $9.2 million and up 15% year-over-year to $209.2 million whilenet income was $5.1 million, better than guidance by $11.1 million and an improvement of $9.5 million year-over-year.

  • [By Peter Graham]

    A long term performance chart shows shares of Glu Mobile and peer Zynga Inc (NASDAQ: ZNGA)all over the place for investors and savvy traders who could have profitably traded theirshares:

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap social media gaming stockZynga Inc (NASDAQ: ZNGA) is scheduled for after the market closes on Thursday (February 9th). Our SmallCap Network Elite Opportunity (SCN EO) portfolio has repeated suggested trading Zynga Inc with aJanuary 2014 SCN EO newsletter noting the following:

  • [By Andrew Tonner]

    IPOs like Snap are a rare breed. In looking for companies comparable to it, I looked for listings that sported a post-IPO valuation above $5 billion, went pubic after 2010, and employ a consumer-facing business model. This resulted in an admittedly small sample of highly hyped tech IPOs including Facebook (NASDAQ:FB), Twitter (NYSE:TWTR), Groupon (NASDAQ:GRPN), and Zynga (NASDAQ:ZNGA). For transparency’s sake, I opted to not include Chinese e-commerce giant Alibaba in this list because its geographic focus and scale made it fundamentally different than the above tech IPOs, although including it wouldn’t have changed the outcome of this analysis.

  • [By David Zeiler]

    Institutional Venture Partners was the VC firm that led the round. IVP focuses on tech startups, having backed such names as Snap Inc. (NYSE: SNAP), Twitter Inc. (NYSE: TWTR), Zynga Inc. (Nasdaq: ZNGA), and Dropbox Inc.

Top 10 Safest Stocks To Watch For 2018: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dropped 20 percent to $1.12. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Top 10 Safest Stocks To Watch For 2018: Pampa Energia S.A.(PAM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, the utilities sector proved to be a source of strength for the market. Leading the sector was strength from Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG) and Pampa Energia S.A. (ADR) (NYSE: PAM).

  • [By Lisa Levin]

    On Tuesday, utilities shares slipped by just 0.5 percent. Meanwhile, top gainers in the sector included Pampa Energia S.A. (ADR) (NYSE: PAM), up 2 percent, and Chesapeake Utilities Corporation (NYSE: CPK) up 3 percent.

Top 10 Safest Stocks To Watch For 2018: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, healthcare shares fell by 0.91 percent. Meanwhile, top losers in the sector included Alere Inc (NYSE: ALR), down 8 percent, and Exelixis, Inc. (NASDAQ: EXEL), down 10 percent.

  • [By Chris Lange]

    Exelixis Inc. (NASDAQ: EXEL) saw its shares make a handy gain on Wednesday after the company was tapped by the U.S. Food and Drug Administration (FDA). Specifically, the FDA has approved Cabometyx (cabozantinib) tablets for the expanded indication of patients with advanced renal cell carcinoma (RCC), which is the most common form of kidney cancer in adults.

Top 5 Safest Stocks To Buy Right Now

Chipotle (NYSE:CMG) is now one of the major focuses of activist investor Bill Ackman after Pershing Square dumped its Valeant Pharmaceuticals (NYSE:VRX) stake. Ackman showed he has the patience to wait out a turnaround, as exhibited with VRX.

However, Ackman is cleaning up his portfolio. He’s also positioned himself, per an SEC filing in March, to be able to sell his near 3 million stake from time to time without having to file multiple registration statements.

Yet, CMG has started to regain strength. The stock is up 25% in 2017. This could give Ackman the encouragement to ride this out. Pershing’s average cost is right around $415 a share.

Top 5 Safest Stocks To Buy Right Now: Netease.com Inc.(NTES)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    Shares of Hangzhou, China-based NetEase Inc (NASDAQ:NTES)popped 14% in the Feb 16th trading session after the company reported stellar Q4 and full-year 2016 earnings on Feb 15th after market close. The Chinese online gaming giant delivered an EPS of $4.30 on revenues of $1.74B beating EPS estimates by $0.86 and revenue estimates by $16oM. NetEase’s revenue grew by an impressive 53.1% YoY for Q4 and 67.7% for the full year 2016. On the back of these strong numbers, NTES stock closed at an all-time high of $298.73 in yesterday’s trading session. NTES stock might have gone up very high too soon. There could be a correction around the corner but still NTES stock is a great long-term proposition with much more upside left. Here’s why.

  • [By Joe Tenebruso]

    Shares ofNetEase (NASDAQ:NTES)popped 20.1% last month, according to data provided byS&P Global Market Intelligence, as the Chinese internet technology company’s strong fourth-quarter earnings report was applauded by investors.

Top 5 Safest Stocks To Buy Right Now: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
    Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today!   Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’d use today’s weakness to buy Merck (MRK) , Eli Lilly (LLY) , Pfizer (PFE) and Allergan (AGN) , an Action Alerts PLUS holding.

  • [By Chris Lange]

    Eli Lilly & Co. (NYSE: LLY) saw its shares in free fall on Wednesday, not from the usual rhetoric of politicians or even the election, for that matter, but a late-stage trial failure. As 24/7 Wall St. has said time and again, clinical trials can make or break biotech and pharma companies. In this case Eli Lilly hit new 52-week lows, not seen since 2014 and this will not be a loss that Eli Lilly will easily forget. Effectively, the company announced results from its Phase 3 solanezumab trial in people with mild dementia due to Alzheimers disease (AD).

  • [By Johanna Bennett]

    Eli Lilly & Co. (LLY) and Biogen (BIIB) are far from the only two drug makers racing to deliver a new treatment for Alzheimers disease. But they are pretty much leading the pack.

    The market for an effective therapy that actually slows the progression of the disease would likely generate billions of dollars in annual sales. It is quite literally the drug industrys version of the holy grail.

    And according to Barclays analysts Geoff Meacham and Paul Choi, the next few weeks could prove to be one of the most fertile periods in Alzheimers disease research since 2008.

    We think the most likely outcome for Lilly’s Phase 3 EXPEDITION 3 (E3) solanezumab trial is the primary cognition (ADAS-Cog14) endpoint is met (just achieving statistical significance with a p-value <0.05) and mixed results on the secondary endpoints including function (ADL), which we believe should be good enough to support a regulatory submission. While aducanumab has a marginally different mechanism of action, we nevertheless expect BIIB shares to trade in sympathy to Lilly.

    Implications for Biogen and Merck: The E3 results are likely to result in volatility for Biogen (up 20-30%, down 10-15%) as Alzheimer’s drives both long-term growth and M&A value even though aducanumab works differently from solanezumab.

    Aducanumab dose titration data is expected at the CTAD meeting (San Diego, Dec. 9). Merck’s Phase 2/3 EPOCH verubecestat (BACE) trial is scheduled to finish in June 2017 but unlike E3, PET scans/CSF tests for A were not an inclusion criteria. We think Merck shares could move 3% to 5% in either direction in sympathy to E3.

    At $76.58, Lillys share price has fallen more than 9% over the past year, while Biogen has climbed more than 9% over the same span.

  • [By David Zeiler]

    Pharma stocks shot up in the wake of Donald Trump’s victory. Eli Lilly and Co. (NYSE: LLY) and Merck & Co. (NYSE: MRK) both rose about 6%, while Pfizer Inc. (NYSE: PFE) jumped 7%.

Top 5 Safest Stocks To Buy Right Now: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION(SAIC)

Advisors’ Opinion:

  • [By Monica Gerson]

    Wall Street expects Science Applications International Corp (NYSE: SAIC) to report its quarterly earnings at $0.74 per share on revenue of $1.15 billion. SAIC shares gained 0.96 percent to $57.87 in after-hours trading.

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

  • [By Monica Gerson]

    Science Applications International Corp (NYSE: SAIC) is estimated to report its quarterly earnings at $0.74 per share on revenue of $1.15 billion.

Top 5 Safest Stocks To Buy Right Now: ChannelAdvisor Corporation(ECOM )

Advisors’ Opinion:

  • [By Lisa Levin]

    ChannelAdvisor Corp (NASDAQ: ECOM) shares dropped 24 percent to $10.85 following Q4 results. ChannelAdvisor reported Q4 net income of $5.8 million on revenue of $31.8 million.

Top 5 Safest Stocks To Buy Right Now: Medtronic plc(MDT)

Advisors’ Opinion:

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.

    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.

    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By Keith Fitz-Gerald]

    I’ve long thought that Medtronic (NYSE:MDT) would be a suitable buyer, as was the subject of unconfirmed rumors last month. However, I could also envision a defense contractor moving in simply because so much of the intellectual property could easily crossover to military applications. Or, even Google X for that matter.

  • [By George Budwell, Keith Speights, and Cory Renauer]

    So, to help investors separate the wheat from the chaff, we asked our Foolish contributors which stocks they thought are worth owning until at least 2030. These three healthcare specialists recommended Medtronic (NYSE:MDT), Johnson & Johnson (NYSE:JNJ), andIntuitive Surgical (NASDAQ:ISRG). Read on to find out why.

  • [By Todd Campbell]

    At Medtronic (NYSE:MDT), one of the country’s largest medical-device companies, these sensors are even attached to an insulin pump patients wear that canautomatically administer insulin as it’s needed.

  • [By ]

    Medical device makers will also be in the price-control crosshairs. If the government can mandate drug prices, the same can be expected for pacemakers, artificial joints and other devices. Companies such as Medtronic (NYSE: MDT) and previously mentioned pharma giant Johnson & Johnson will find themselves adjusting to a new paradigm.

usa stock exchange

MannKind (MNKD) investors saw Afrezza scripts come in for the week of 11/10 slightly higher than the previous week, but essentially flat. This is a period where traction is needed if MannKind hopes to hit the re-stated low end of net revenue guidance of $6 million. Simply stated, the company needs sales to ramp up substantially in a time period where it is typically tough to demonstrate sales traction with prescription drugs. The data this week is the first data that includes the potential impacts of the regional television advertising campaign launched by MannKind on November 6th. Ad campaigns take time to bring about maximum effectiveness, so investors should not anticipate or expect an overnight shift in script sales. In the near term, patients with existing appointments that see the ad may be compelled to ask their doctor about Afrezza. In the longer term, the benefit may grow because the advertisement may compel a patient to schedule an appointment and inquire. One challenge that remains is that insurance coverage on Afrezza is far from optimal, and while a patient may ask about the drug, they may not act on it after getting a script because of a lack of coverage or the level of out of pocket expense. Like anything, there are positives and negatives to consider so that you as an investor can arrive at a realistic assessment and opinion.

usa stock exchange: Pan American Silver Corp.(PAAS)

Advisors’ Opinion:

  • [By Jim Cramer]

    The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Metals & Mining industry. The net income has significantly decreased by 231.0% when compared to the same quarter one year ago, falling from -$20.25 million to -$67.05 million.

     

  • [By Laurie Kulikowski]

    We rate PAN AMERICAN SILVER CORP as a Sell with a ratings score of D. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company’s weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. 

  • [By JPMorgan]

    The weak silver sentiment has raised PAAS’ dividend yield to 2.8% which we feel is well supported by PAAS’ strong balance sheet and its healthy liquidity position of $566mn. The company is also advancing two growth projects, expected to add 5moz of silver and 128koz of gold pa to its production from 2018. Its costs are also improving, helped by devalued operating currencies and productivity improvements. 

usa stock exchange: ChannelAdvisor Corporation(ECOM )

Advisors’ Opinion:

  • [By Lisa Levin]

    ChannelAdvisor Corp (NASDAQ: ECOM) shares dropped 24 percent to $10.85 following Q4 results. ChannelAdvisor reported Q4 net income of $5.8 million on revenue of $31.8 million.

usa stock exchange: CSX Corporation(CSX)

Advisors’ Opinion:

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian spoke about unusually high options trading activity in CSX Corporation (NASDAQ: CSX). The stock traded around 15 percent higher since the Presidential election and options traders are betting that it is going to jump additional 8 percent. Traders were buying the February 38 calls on Wednesday for approximately $0.80. Najarian decided to follow the trade and he bought a call spread in CSX. He's going to be in the position for a month or two.

  • [By Rich Duprey]

    I ran a screen to identify the best-performing stocks from the S&P 500 in January. The top three performers during the month were Alcoa (NYSE:AA), CSX (NASDAQ:CSX), and NRG Energy (NYSE:NRG). Let’s see why they were the big standouts and whether they can keep it going.

  • [By Brett Hershman]

    The Swiss bank said it was raising first-quarter estimates on four of the six rails it covers, with updated estimates above consensus on Canadian National Railway (USA) (NYSE: CNI), CSX Corporation (NASDAQ: CSX) and Kansas City Southern (NYSE: KSU), which is seen to show upside against low expectations.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, American Express (NYSE:AXP) and CSX (NASDAQ:CSX)both beat the market following quarterly earnings news.

    Image source: Getty Images.

  • [By Dan Caplinger]

    The railroad business has been tough lately, and companies like CSX (NASDAQ:CSX) have had to deal with the ups and downs of the industrial economy and its impact on shipping volume. Coming into Wednesday’s first-quarter financial report, however, CSX investors were excited about the prospects for a resurgence in the railroad’s growth prospects.

usa stock exchange: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

usa stock exchange: International Game Technology(IGT)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday was another strong day on Wall Street, with major benchmarks posting gains across the board. The S&P 500 reached another all-time high on strength from an upbeat view of the economy and good earnings results from major companies in the retail sector. Although energy prices sagged, investors seemed to focus on the cost savings that consumers would enjoy from cheaper gasoline rather than the profit hit that major oil and natural gas companies might suffer. Still, not every stock participated in the rally, and International Game Technology (NYSE:IGT), Genesco (NYSE:GCO), and Ensco (NYSE:ESV) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Michael Flannelly]

    Analysts at Sterne Agee noted on Monday that International Game Technology’s (IGT) fiscal 2014 growth is stronger than it appears. As such, the analysts raised the price target on the casino gaming equipment manufacturer.

    The analysts maintain a “Buy” rating on IGT and now see shares reaching $25, up from the previous target of $23. This new price target suggests a 23% upside to the stock’s Friday closing price of $20.32.

    “Excluding FY13 Canadian VLT sales, which do not recur in FY14, consensus FY14 EPS growth is ~14% versus ‘in-print’ consensus EPS growth of ~4%,” Sterne Agee analyst David Bain said. “We believe IGT’s peer-low stock valuation is partly driven by a misinterpretation of forward growth using ‘in-print’ FY14 EPS projections.”

    Futhermore, the firm raised IGT’s fourth quarter EPS estimates from 33 cents to 34 cents.

    IGT shares were inactive during pre-market trading on Monday. The stock is up 43.4% year-to-date.

  • [By Dan Caplinger]

    Yet even though the overall market remained resilient in the face of some threats to positive sentiment among investors, some stocks posted substantial losses. Stratasys (NASDAQ:SSYS), International Game Technology (NYSE:IGT), and Momo (NASDAQ:MOMO) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

usa stock exchange: Credicorp Ltd.(BAP)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Bank of Nova Scotia (The) (NYSE: BNS): Free Stock Analysis Report
     
    Banco Bilbao Viscaya Argentaria S.A. (NYSE: BBVA): Free Stock Analysis Report
     
    Credicorp Ltd. (NYSE: BAP): Free Stock Analysis Report
     
    Bank of N.T. Butterfield & Son Limited (The) (NTB): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.

Top 10 Blue Chip Stocks To Own Right Now

If you're like most investors, you've been led to believe that it's impossible to earn large amounts of investment income without taking big risks.   This idea – which you'll hear from many financial advisors and brokers – is simply wrong.   It is possible to earn double-digit annual yields on your money – safely – by selling options.   So why doesn't everyone use this strategy to earn consistent income streams? Below, you'll find the five common objections I've heard from readers or that I've found on the Internet… and my responses to them.   REASON NO. 1: Option-selling strategies like covered calls are too risky. You'll earn 5% in premiums, but if the stock falls 25%, you're still down big!   This objection is 100% valid. The way most people approach covered calls is risky. (If you're unfamiliar with covered calls, I encourage you to read this essay.) These folks buy risky stocks because risky, volatile stocks typically offer larger cash premiums than safe, stable blue chips. But most people end up losing on risky covered-call positions because their stocks fall in value.

Top 10 Blue Chip Stocks To Own Right Now: Pilgrim's Pride Corporation(PPC)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Bob Evans Farms breaking out while a comparison to possible peers in the remaining core business shows the stock had underperformed large caps Hormel Foods Corporation (NYSE: HRL) andTyson Foods, Inc (NYSE: TSN) and mid cap Pilgrim’s Pride Corporation (NASDAQ: PPC) when it was still in the restaurant business:

  • [By Peter Graham]

    A long term performance chart shows shares ofmid cap Sanderson Farms more than doubling in value while mid cap Pilgrim’s Pride Corporation (NASDAQ: PPC) and large cap Tyson Foods, Inc (NYSE: TSN) have been even better performers albeit shares are below previous highs and have been somewhat volatile:

  • [By John Udovich]

    Thanksgiving is almost here but the exit of both Pilgrim’s Pride Corporation (NYSE: PPC) and Smithfield Foods (NYSE: SFD) to focus on their chicken or pork businesses (the latter was also acquired by the Chinese) leaves just two big Thanksgiving turkey stocks, Hormel Foods Corporation (NYSE: HRL) and Seaboard Corporation (NYSEAMEX: SEB), for investors to consider. According to the American Far Bureau, a 16-pound turkey will (on average) come in at a total of $22.74 this year or roughly $1.42 per pound for a decrease of 2 cents per pound or a total of 30 cents per whole turkey, compared to 2015. The price drop may be a transition back to the norm as the significant bird flu outbreak last year hurt the nations supply of both turkey and eggs.

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanderson Farms doubling in value while mid cap Pilgrim’s Pride Corporation (NASDAQ: PPC) and large cap Tyson Foods, Inc (NYSE: TSN) have been even better performers albeit shares are below their peaks and have been somewhat volatile:

  • [By Peter Graham]

    Mid cap chicken producer Pilgrim’s Pride Corporation (NASDAQ: PPC) reportedQ2 2017 earnings after the market closed Wednesday as short interest remains elevated at 31.17%according to Highshortinterest.comin the wake of the worstbird-flu outbreak in the US whichhad hurt demand and triggered import bans abroad. Net sales were up 11.0% to $2.252 billion while net income attributable to Pilgrim’s Pride Corporation was $233.641 million versus $152.886 million.The earnings release noted:

  • [By Peter Graham]

    The Q4 2016earnings report for mid cap chicken producer Pilgrim’s Pride Corporation (NASDAQ: PPC) scheduled for before the market opens on Thursday(February 9th). Pilgrim’s Pride Corporationis the sixth most shorted stock on the Nasdaq with short interest of 41.76%according to Highshortinterest.com. Theelevated short interest comes in the wake of the worstbird-flu outbreak in the US whichhad hurt demand and triggered import bans abroad.

Top 10 Blue Chip Stocks To Own Right Now: PetroShare Corp. (PRHR)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Just one company joined the calendar, micro-cap gunshot detector ShotSpotter (Pending:SSTI), and one micro-cap company filed, DJ Basin E&P PetroShare (OTCQB:PRHR). We had expected more JOBS-Act filers this week as Monday marked the first day to file for companies preparing for post-Memorial Day launches.

Top 10 Blue Chip Stocks To Own Right Now: Haynes International, Inc.(HAYN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, basic materials shares fell by 1.24 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 12 percent, and McEwen Mining Inc (NYSE: MUX), down 9 percent.

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 0.44 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 5 percent, and Gibraltar Industries Inc (NASDAQ: ROCK), down 4 percent.

  • [By Lisa Levin]

    Basic materials sector was the top gainer in the US market on Monday. Top gainers in the sector included Haynes International, Inc. (NASDAQ: HAYN), Cliffs Natural Resources Inc (NYSE: CLF), and Olympic Steel, Inc. (NASDAQ: ZEUS).

Top 10 Blue Chip Stocks To Own Right Now: ChannelAdvisor Corporation(ECOM )

Advisors’ Opinion:

  • [By Lisa Levin]

    ChannelAdvisor Corp (NASDAQ: ECOM) shares dropped 24 percent to $10.85 following Q4 results. ChannelAdvisor reported Q4 net income of $5.8 million on revenue of $31.8 million.

Top 10 Blue Chip Stocks To Own Right Now: Gas Natural Inc.(EGAS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Gas Natural Inc (NYSE: EGAS) is projected to post its quarterly earnings at $0.23 per share.

    Caleres Inc (NYSE: CAL) is expected to post its quarterly earnings at $0.23 per share on revenue of $632.89 million.

Top 10 Blue Chip Stocks To Own Right Now: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Paul Ausick]

    Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) dropped more than 17% Friday to post a new 52-week low of $60.97 after closing Thursday at $73.70. The 52-week high is $172.75. Volume of more than 10 million shares traded was about 12 times the daily average. The FDA on Thursday issued a warning letter on the company’s liver disease treatment.

  • [By Peter Graham]

    Small cap liver biopharmaceutical stock Intercept Pharmaceuticals Inc (NASDAQ: ICPT) reportedQ2 2017 earnings before the market opened on Monday with both the top and bottom lines beating expectations plus the Companyreported that amid-stage clinical trial met its primary endpoint; but sharesended the day down13.26%. Intercept Pharmaceuticals recognized $30.4 million of net sales of Ocaliva for Q2 2017 versus $75k and a net loss of $86.6 million versus a net loss of $77.3 million. Ocaliva was approved by the U.S.FDA in May 2016 for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. As of June 30, 2017,the Companyhad cash, cash equivalents and investment securities available for sale of approximately $550.3 million versus$689.4 million as of December 31, 2016. The CEO commented:

Top 10 Blue Chip Stocks To Own Right Now: International Lithium Corp. (ILHMF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    International Lithium [TSXV:ILC] (OTCPK:ILHMF) – Price = CAD 0.13

    International Lithium (ILC) is a small lithium explorer/project generator with four joint venture lithium projects, and one fully-owned lithium project:

Top 10 Blue Chip Stocks To Own Right Now: Coach, Inc.(COH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

  • [By Jayson Derrick]

    Honorable Mention: Buy-rated Coach Inc (NYSE: COH) with a $49 price target.

    Energy: Halliburton

    Halliburton Company (NYSE: HAL) is a top energy pick for four reasons: 1) the company’s significant leverage to the U.S. onshore market, 2) potential for incremental margin growth, 3) expectations for positive earnings revision and 4) strong balance sheet and a “well respected” management team.

  • [By Ben Levisohn]

    Coach (COH) rose to the top of the S&P 500 today after reports that Kate Spade (KATE) had put itself up for sale caused shares of fashion-accessory retailers to rise.

    Agence France-Presse/Getty Images

    Coach gained 2% to $35.14 at 4:20 p.m. today, while the S&P 500 dropped 0.8% to 2,249.92.

    Wells Fargo’s Ike Boruchow lists Coach among the companies that could be interest in buying Kate Spade:

    Today, the Wall Street Journal reported that Kate Spade & Co is considering a sale of the company, following pressure from activist investors given the volatile performance ever since Kate Spade became a mono brand company over 2 years ago. The article cites thatKate Spade has hired an investment bank and has reached out to possible buyers (including other retailers) althoughKate Spade has not responded. This comes at a time when brand houses like VF Corp. (VFC), PVH Corp. (PVH), Hanesbrands (HBI), Michael Kors Holdings (KORS), and Coach have said they are looking to make a branded acquisition, andKate Spade could be one of the strongest candidates. While other brands are seeing negative comps, pulling back on wholesale exposure or restructuring,Kate Spade continues to grow.

    Coach’s market capitalization rose to $9.9 billion today from $9.7 billion yesterday. It reported net income of $461 million on sales of $4.5 billion in fiscal 2016.

  • [By Ben Levisohn]

    When we examined historical transactions in the specialty retail sector, we noticed a wide range of valuations. Select relevant transactions to consider would be ~2x EV/Sales Coach (COH) paid for Stuart Weitzman, Samsonites acquisition of Tumi at 14x EV/EBITDA, 13x EV/EBITDA for Joseph A. Banks by Mens Wearhouse (TLRD) and Kerings acquisition of Volcom for 18x EV/EBITDA. We believe potential valuation could be as high as ~2x EV/ Sales and ~14x EV/EBITDA given Kate Spade’s unique growth profile to expand to ~$4bn in revenue (from $1.4bn in FY16) and improving profitability from 12% EBIT margin TY to at least HTeens-LDD, in our view (Coach is 18.7% and Michael Kors (KORS) is 21.3%). On these two metrics, Kate Spade would be valued at $21-23…

  • [By Ben Levisohn]

    …formal language on deal prospects articulates process is proceeding in a timely manner with no definitive timetable and no assurance that process will result in a transaction. We still expect a deal to happen, but do lower our probability from 80% to 70% given the likelihood that potential buyer(s) and KATE have not agreed on a clearing price in earlier rounds of negotiation. We believe a bidder such as Coach (COH) does not want to overpay, is disciplined about managing ROIC, and returns and synergies split may be more rational at an offer price in the range of $22-25. We continue to believe KATE has a long global growth runway ahead with opportunities for store growth abroad, further expansion into non-handbag categories, and supply + digital synergy potential…We rate KATE Market Perform and lower our price target to $21 (was $27). Our updated valuation is based on ~10x our FY18E adj. EBITDA or $284mm.

  • [By Ben Levisohn]

    Kate Spade (KATE) caught a bounce on Wednesday when the Wall Street Journalreported that it was actively seeking a buyer. Since then, we’ve learned that the fashion accessories retailer looks set to auction itself off to the highest bidder, with the process potentially beginning next month, with bidders potentially including Coach (COH) and Michael Kors (KORS). In a note today, SunTrust Robinson Humphrey analystPamela Quintiliano and team contend that Kate Spade could fetch as much as $23 a share:

Top 10 Blue Chip Stocks To Own Right Now: Enphase Energy, Inc.(ENPH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    UPDATE: I stand corrected. There does appear to be a reason for First Solar’s market-leading move today. Axiom Capital’s Gordon Johnson attributes the rise to the $10 million investment in Enphase Energy (ENPH), which makes “microinverter systems for the solar photovoltaic industry,” by investors T.J. Rodgers and John Doerr.

Top 10 Blue Chip Stocks To Own Right Now: Gaming and Leisure Properties, Inc.(GLPI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 3.25 percent to $31.90 in pre-market trading. Gaming and Leisure Properties priced offering of 10.53 million shares of common stock for gross proceeds of $333 million.

  • [By Seth McNew]

    One way Penn has been able to unlock extra value is by spinning off a portion of operations as a real estate investment trust (REIT) as a way to split up the physical property from the gaming operations. Following that 2013 creation of Gaming and Leisure Properties Inc(NASDAQ:GLPI),Penn essentially pays leasing fees to the REIT so it can focus on operations with a leaner balance sheet. Here’s a more in-depth analysis of the upside of Penn’s REIT model.

stock ticker

The ad industry spends $111 billion a year convincing the public to buy whatever it’s selling.

On occasion, the ad agencies go a few steps too far to promote their products and wind up spewing blatant falsehoods.

Such outright advertising lies often lead to expensive court battles, share-price drops, and, sometimes, a company’s total collapse.

From bogus cancer cures to weight-loss gimmicks, here are six of the biggest lies ever told by corporations to swindle U.S. consumers. Each one worked — for a while…

6 of the Biggest Advertising Lies Ever Told

Big Advertising Lie No. 1: Airborne

Airborne – the herbal supplement marketed as “the one designed by a school teacher” — got failing grades when news broke in 2008 that no scientific studies backed its claims that its product could kill flu and cold germs.

stock ticker: Griffin Industrial Realty, Inc.(GRIF)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, cyclical consumer goods & services shares fell 0.01 percent. Meanwhile, top losers in the sector included Griffin Industrial Realty Inc (NASDAQ: GRIF), down 5 percent, and Movado Group, Inc (NYSE: MOV) down 5 percent.

stock ticker: CVS Health Corporation(CVS)

Advisors’ Opinion:

  • [By Keith Speights, Sean Williams, and Cory Renauer]

    So when we asked three of our top healthcare contributors to name three of the best stocks to invest in healthcare, it’s not surprising that their responses listed companies in three different industries: medical device makerMasimo (NASDAQ:MASI), pharmacy services giant CVS Health (NYSE:CVS) and biopharmaceutical company Ligand Pharmaceuticals (NASDAQ:LGND). Here’s why these three healthcare stocks stand out as smart picks.

  • [By WWW.GURUFOCUS.COM]

    For the details of Focused Investors LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Focused+Investors+LLC

    These are the top 5 holdings of Focused Investors LLCZimmer Biomet Holdings Inc (ZBH) – 1,433,300 shares, 6.32% of the total portfolio. Shares added by 23.22%CVS Health Corp (CVS) – 2,120,700 shares, 6.01% of the total portfolio. Shares added by 19.73%Johnson & Johnson (JNJ) – 1,285,900 shares, 5.78% of the total portfolio. Shares reduced by 0.67%American Express Co (AXP) – 1,990,300 shares, 5.68% of the total portfolio. Shares reduced by 0.33%Anthem Inc (ANTM) – 944,800 shares, 5.64% of the total portfolio. Sh

  • [By WWW.THESTREET.COM]

    Target (TGT) had missed projections for the last couple of quarters and didn’t have as strong growth online as some were looking for. Plus, when CVS (CVS) reported its miserable call, the stock got blasted because CVS said its drugstores in Target weren’t anything to write home about. So Target didn’t participate in the great retail rally that we had last week. Now it is front and center after that stronger-than-expected quarter. And make no mistake about it, that quarter was stronger than expected. (Disney and CVS are part of TheStreet’s Trifecta Stocks portfolio.)

stock ticker: ChannelAdvisor Corporation(ECOM )

Advisors’ Opinion:

  • [By Lisa Levin]

    ChannelAdvisor Corp (NASDAQ: ECOM) shares dropped 24 percent to $10.85 following Q4 results. ChannelAdvisor reported Q4 net income of $5.8 million on revenue of $31.8 million.

stock ticker: Buenaventura Mining Company Inc.(BVN)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Somerset Capital Management LLP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Somerset+Capital+Management+LLP

    These are the top 5 holdings of Somerset Capital Management LLPFomento Economico Mexicano SAB de CV (FMX) – 1,268,818 shares, 36.15% of the total portfolio. Shares reduced by 9.36%Yandex NV (YNDX) – 3,352,412 shares, 25.48% of the total portfolio. Shares reduced by 3.61%ICICI Bank Ltd (IBN) – 5,074,899 shares, 13.19% of the total portfolio. Shares reduced by 11.08%Infosys Ltd (INFY) – 1,596,414 shares, 6.95% of the total portfolio. Shares reduced by 15.58%KT Corp (KT) – 1,330,431 shares, 6.41% of the

  • [By Alex McGuire]

    You see, Money Morning Resource Specialist Peter Krauth expects gold prices to gain 15.4% from their current $1,213 level to $1,400 an ounce this year. This rise will lead to an even bigger rally for gold stocks. Since the beginning of 2017, gold prices are up 5.1%. But the gains in gold stocks like Agnico Eagle Mines Ltd. (NYSE:AEM) and Compania de Minas Buenaventura SAA (NYSE ADR: BVN) have doubled and quadrupled the year-to-date gold price return.

stock ticker: ePlus Inc.(PLUS)

Advisors’ Opinion:

  • [By Monica Gerson]

    ePlus Inc. (NASDAQ: PLUS) is estimated to post its quarterly earnings at $1.21 per share on revenue of $284.62 million.

    Tilly’s Inc (NYSE: TLYS) is expected to post a quarterly loss at $0.07 per share on revenue of $119.93 million.

penny stock research

RBC’s Kurt Hallead and Benjamin Owens offer their take on Transocean (RIG) appearance at the RBC Global Energy and Power Conference:

Bloomberg

Our view: Transocvean continues to execute well, with the focus on revenue efficiency bearing fruit over the last several quarters. However, we believeTransocean shares have limited upside until the market gains more confidence in the supply/demand outlook for floating rigs in 2017-18. Currently, fundamentals continue to weaken for floating rigs, and it remains unclear where dayrates and utilization may bottom.

Expects to see 2H16 opportunities in the jackup market:Transocean expects shallow water to be the first area within the offshore market to see increased spending if oil prices remain constructive. The demand for jackups is being driven by independent oil companies and NOCs. The company still expects the deep water rig count to trend lower through at late-2016 or early-2017.

penny stock research: Clean Energy Fuels Corp.(CLNE)

Advisors’ Opinion:

  • [By Jason Hall]

    Natural gas for transportation leader Clean Energy Fuels Corp (NASDAQ:CLNE) has steadily grown and improved the quality of its business and business results over the past several years. Today’s Clean Energy Fuels is leaner, has a stronger balance sheet, and is in a solid position as a market leader in a growth industry.

  • [By Michael Vodicka]

    Clean Energy Fuels Corp. (CLNE) designs, builds and operates natural gas filling stations in the United States. The company supplies compressed natural gas (CNG) and liquefied natural gas (LNG), serving a fleet of 650 customers, more than 32,000 natural-gas vehicles while owning or supplying more than 350 filling stations in 32 states.

  • [By Lisa Levin]

    In trading on Wednesday, energy shares fell by 1.72 percent. Meanwhile, top losers in the sector included Clean Energy Fuels Corp (NASDAQ: CLNE), down 5 percent, and Frontline Ltd. (NYSE: FRO), down 7 percent.

penny stock research: GenMark Diagnostics, Inc.(GNMK)

Advisors’ Opinion:

  • [By Lisa Levin]

    GenMark Diagnostics, Inc (NASDAQ: GNMK) shares shot up 20 percent to $10.54. Cowen & Co. upgraded GenMark Diagnostics from Market Perform to Outperform.

penny stock research: Snap-On Incorporated(SNA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Coming up on this episode of Mad Money: Cramer interviews Nick Pinchuk, CEO of Snap-on (SNA) . Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By WWW.MONEYSHOW.COM]

    Snap-on (SNA)

    Snap-on, which is more than 100 years old, provides hand and power tools for individuals and professionals, including auto-shop tools and auto diagnostic equipment.

  • [By John Divine]

    Snap-on Incorporated (SNA) is my choice for the Best Stocks for 2016 competition. At a market cap of $10 billion, I doubt it will double over the next year, as some of the smaller companies in this competition might be able to.

    That said, Snap-on, which manufactures and markets hand tools and diagnostic equipment, is a rock-solid company with an attractive valuation and impressive growth. It goes for 22 times earnings, pays a consistent and modest dividend, and has been around since 1920.

    As cars get more tech-heavy and complicated, newer tools and better diagnostics will be needed — and that’s SNA’s bread ‘n’ butter. 

penny stock research: ChannelAdvisor Corporation(ECOM )

Advisors’ Opinion:

  • [By Lisa Levin]

    ChannelAdvisor Corp (NASDAQ: ECOM) shares dropped 24 percent to $10.85 following Q4 results. ChannelAdvisor reported Q4 net income of $5.8 million on revenue of $31.8 million.